If you are a healthcare professional, please click here.
Medical Information Portal for Healthcare Providers: https://medinfo.seqirus.com/
PRODUCTS
OUR PRODUCTS
This information is intended for U.S. residents.
Here you will find a listing of our products available in the U.S.
Consumers should contact their healthcare professional for further advice.
| AFLURIA® TRIVALENT, Influenza Vaccine Suspension for Intramuscular Injection |
|
AFLURIA® TRIVALENT is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. AFLURIA TRIVALENT is approved for use in persons 6 months of age and older MORE INFORMATION |
| FLUAD® TRIVALENT (Influenza Vaccine, Adjuvanted) Suspension for Intramuscular Injection |
|
FLUAD TRIVALENTis an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. FLUAD TRIVALENT is approved for use in persons 65 years of age and older. Approval is based on the immune response elicited by FLUAD TRIVALENT. Data demonstrating a decrease in influenza disease after vaccination with FLUAD TRIVALENT are not available. MORE INFORMATION |
| FLUCELVAX® TRIVALENT (Influenza Vaccine) Suspension for Intramuscular Injection |
|
FLUCELVAX TRIVALENT is an inactivated vaccine indicated for active immunization for the prevention of influenza disease caused by influenza virus subtypes A and type B contained in the vaccine. FLUCELVAX TRIVALENT is approved for use in persons 6 months of age and older. MORE INFORMATION |
The trademarks marked ® are registered by CSL Seqirus U.K. Limited or its affiliates in one or more jurisdictions, unless indicated otherwise.
Pandemic Response Solutions
As a global leader in influenza vaccine manufacturing, CSL Seqirus offers a portfolio of pandemic vaccines and services which are tailored to rapid response.
Learn more
Important Safety Information for AFLURIA
Consumer
What is AFLURIA® (Influenza Vaccine)?
AFLURIA is a vaccine that helps protect people aged 6 months and older from the flu. Vaccination with AFLURIA may not protect all people who receive the vaccine.
Who should not receive AFLURIA?
You should not receive AFLURIA if you have a history of severe allergic reactions (e.g., anaphylaxis) to any component of the vaccine including egg protein, or to a previous dose of any influenza vaccine.
Before receiving AFLURIA, tell your healthcare provider about all medical conditions, including if you:
- have ever had Guillain-Barré syndrome (severe muscle weakness) within six weeks after getting a flu vaccine. The decision to give AFLURIA should be made by your healthcare provider, based on careful consideration of the potential benefits and risks.
- have problems with your immune system or are taking certain medications that suppress your immune system, as these may reduce your immune response to the vaccine
What are the most common side effects of AFLURIA?
- pain, tenderness, redness, itching, bruising, and/or swelling where the vaccine was given
- headache
- muscle aches
- feeling unwell (malaise)
Additional side effects seen in children include:
- irritability
- diarrhea
- loss of appetite
- extreme tiredness
These are not all the possible side effects of AFLURIA. You can ask your healthcare provider for more information and for advice about any side effects that concern you.
What do I do if I have side effects?
Report any severe or unusual side effects to your healthcare provider.
To report SUSPECTED ADVERSE REACTIONS, contact CSL Seqirus at 1-855-358-8966 or VAERS at 1-800-822-7967 or www.vaers.hhs.gov.
Before receiving this vaccine, please see the full prescribing information for AFLURIA. You can ask your healthcare provider or pharmacist for information about AFLURIA that is written for healthcare professionals.
US/CORP/0919/0170